UBS Group’s Spectranetics Corp SPNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-718
Closed -$27K 8331
2017
Q2
$27K Sell
718
-911
-56% -$26.3K ﹤0.01% 6090
2017
Q1
$48K Sell
1,629
-12,694
-89% -$338K ﹤0.01% 5561
2016
Q4
$351K Buy
14,323
+13,820
+2,748% +$325K ﹤0.01% 4375
2016
Q3
$13K Sell
503
-800
-61% -$18.7K ﹤0.01% 6635
2016
Q2
$24K Sell
1,303
-700
-35% -$12.3K ﹤0.01% 6168
2016
Q1
$29K Sell
2,003
-10,927
-85% -$151K ﹤0.01% 5928
2015
Q4
$194K Buy
12,930
+5,050
+64% +$66.7K ﹤0.01% 4696
2015
Q3
$92K Sell
7,880
-6,364
-45% -$114K ﹤0.01% 5303
2015
Q2
$327K Buy
14,244
+2,024
+17% +$56.5K ﹤0.01% 4444
2015
Q1
$425K Buy
12,220
+3,017
+33% +$103K ﹤0.01% 4274
2014
Q4
$319K Buy
+9,203
New +$287K ﹤0.01% 4607

UBS Group's SPNC Position: Q3 2017 in Review

UBS Group sold out of Spectranetics Corp (SPNC) in Q3 2017, closing a stake of 718 shares — an estimated $27K sold.

UBS Group first reported a position in SPNC in Q4 2014 and held it in 11 quarters. The position peaked at $425K in Q1 2015. 0 funds tracked by Wall St. Rank hold SPNC as of Q3 2017.

  • UBS Group reported no remaining Spectranetics Corp position as of Q3 2017 after selling out during the quarter.
  • UBS Group sold 718 Spectranetics Corp shares in Q3 2017, an estimated $27K.
  • UBS Group first reported a position in Spectranetics Corp in Q4 2014 and held it in 11 quarters.
  • UBS Group's Spectranetics Corp position peaked at $425K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Spectranetics Corp as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.